Phase 4 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder for at least 3 months before the screening appointment
- You have been diagnosed with at least mild tardive dyskinesia (involuntary movements caused by certain psychiatric medications) for at least 3 months before the screening appointment
Who may not be able to join:
- You have Parkinson's disease or other involuntary movement problems that are more noticeable than your tardive dyskinesia
- You have been diagnosed with a moderate or severe substance use disorder (such as alcohol or drug dependency) within the last 6 months
- You have a history of a heart condition called long QT syndrome, an irregular heartbeat (heart rhythm problems), or serious liver disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Development Lead, Neurocrine Biosciences
Phone: 1-877-641-3461
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in the Abnormal Involuntary Movement Scale (AIMS) Dyskinesia Total Score (AIMS 1-7) at Week 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.